NN5401-4149 A multi-centre, open-label, single-arm, non-interventional, post marketing sur-veillance (PMS) study of insulin degludec /insulin aspart in patients with diabetes mellitus in routine clinical practice in India

29/08/2014
02/04/2024
EU PAS number:
EUPAS6587
Study
Finalised
Documents
Study protocol
Initial protocol
English (317.23 KB - PDF) View document
Study results
Study results
English (1.79 MB - PDF) View document
Study report
Other information